DAINERIS CRESPO VELAZCO: Open Payments
NPI 1487330429 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 46 payments from 10 companies in 2025. Trend: 2023 $139 · 2024 $387 · 2025 $828
Food & beverage: $828
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 9 | $220 |
| Aimmune Therapeutics, Inc. | 13 | $167 |
| ABBVIE INC. | 8 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| Phathom Pharmaceuticals, Inc. | 5 | $49 |
| VIVUS LLC | 1 | $21 |
| Exact Sciences Corporation | 1 | $16 |
| Braintree Laboratories, Inc. | 1 | $15 |
Products named: IBSRELA, ZENPEP, RINVOQ, XIFAXAN, DUPIXENT, VOQUEZNA, SKYRIZI, ENTYVIO.
Industry payments across FL — which companies pay providers there.
